Antiretroviral Agents in HIV-1

Antiretroviral Agents in HIV

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/65244

Contents of this Issue

Navigation

Page 9 of 25

Selecting a Treatment Regimen Table 5A. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Drug Abacavir (ABC) Ziagen® ABC/ZDV/3TC Trizivir® ABC/3TC Epzicom® Formulation 300 mg tablets or 20 mg/mL oral solution ABC 300 mg + ZDV 300 mg + 3TC 150 mg Dosing Recommendations 300 mg bid or 600 mg once daily ▶ Take without regard to meals 1 tablet bid ABC 600 mg + 3TC 300 mg 1 tablet once daily Didanosine (ddI) Videx EC® Generic ddI EC Videx EC® 125, 200, 250, 400 mg capsules ▶ Buffered tablets (non-EC) no longer available Videx® 10 mg/mL oral solution Body weight ≥ 60 kg: 400 mg once dailya ▶ With TDF, 250 mg once daily Body weight < 60 kg: 250 mg once dailya ▶ With TDF, 200 mg once daily ▶ Take 1/2 hour before or 2 hours after a meal a Preferred dosing with oral solution is bid (total daily dose divided into 2 doses) Emtricitabine (FTC) Emtriva® FTC/TDF/EFV Atripla® FTC/TDF/RPV Complera™ FTC/TDF Truvada® 8 200 mg hard gelatin capsule or 10 mg/mL oral solution FTC 200 mg + TDF 300 mg + EFV 600 mg FTC 200 mg + TDF 300 mg + RPV 25 mg 200 mg capsule once daily or 240 mg (24 mL) oral solution once daily ▶ Take without regard to meals 1 tablet at or before bedtime ▶ Take on an empty stomach to reduce side effects One tablet once daily with meal FTC 200 mg + TDF 300 mg 1 tablet once daily Also available in: Also available in:

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 - Antiretroviral Agents in HIV